Delivery Order SPE2DB20D1047-SPE2DB24FF61K
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,601.99, is for the delivery of PROQUAD VIALS and has a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide the requested pharmaceutical products to support military treatment programs and facilities. This order was placed...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of PROQUAD VIALS valued at $6,407.96. The contract has a completion date of March 18, 2024 and was awarded on February 26, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is serving as the prime contractor for this delivery order, which is not designated as a set-aside contract. AmerisourceBergen...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS. The contract has a completion date of March 18, 2024 and a potential value of $4,805.97. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of PROQUAD VIALS. The contract has a potential value of $3,203.98 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract worth $32,039.80 for PROQUAD VIALS. The contract has a firm fixed price and an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of PROQUAD VIALS. The $4,805.97 order has a completion date of February 16, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $16,019.90 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS medical products. The contract has a ceiling value of $1,570.54 and a completion date of May 23, 2024. This award is issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROQUAD VIALS and other pharmaceutical products and medical supplies. This delivery order, valued at $3,203.98, has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The contract does not have a...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB24FF61KDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROQUAD VIALS to support military treatment programs and facilities. The contract, valued at $7,363.93, has a completion date of May 2, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This recent $7,363.93 award is a task order issued under the larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 4/11/24 |